60 related articles for article (PubMed ID: 23866598)
1. Roxadustat reduces left ventricular mass index compared to rHuEPO in haemodialysis patients in a randomized controlled trial.
Tan W; Wang X; Sun Y; Wang X; He J; Zhong L; Jiang X; Sun Y; Tian E; Li Z; He L; Hao Y; Tang B; Hua W; Ma X; Yang J
J Intern Med; 2024 May; 295(5):620-633. PubMed ID: 38343089
[TBL] [Abstract][Full Text] [Related]
2. Roxadustat Versus Erythropoietin: The Comparison of Efficacy in Reversing Ventricular Remodeling in Dialysis Patients with Anaemia.
Wang MY; Liu XQ; Jiang TT; Liu WT; Huang Y; Huang YL; Jin FY; Zhao Q; Wu QY; Wang GH; Ruan XZ; Ma KL
Int J Med Sci; 2024; 21(4):703-713. PubMed ID: 38464833
[No Abstract] [Full Text] [Related]
3. Role of Hypertension and Anaemia in Left Ventricular Remodelling in Patient with Renal Allograft in the First Post-transplant Year.
Jasminka D; Rasic S; Rebic D; Uncanin S
Mater Sociomed; 2015 Apr; 27(2):104-7. PubMed ID: 26005386
[TBL] [Abstract][Full Text] [Related]
4. Should echocardiogram be undertaken routinely when a child has severe iron deficiency anaemia?
Lamsal R; Walkup J
Paediatr Int Child Health; 2024 May; 44(1):34-38. PubMed ID: 38321653
[TBL] [Abstract][Full Text] [Related]
5. Application of the 2016 ASE-EACVI Criteria for the Assessment of Diastolic Function in Arterial Hypertension.
Canciello G; Izzo R; Bossone E; Piccolo R; Pacella D; Ferrara F; Lembo M; Manzi MV; Carbone A; Mancusi C; Simonetti F; Giugliano G; Morisco C; Cittadini A; Esposito G; Losi MA
High Blood Press Cardiovasc Prev; 2024 Jun; ():. PubMed ID: 38879642
[TBL] [Abstract][Full Text] [Related]
6. Diastolic function in chronic kidney disease.
de Simone G; Mancusi C
Clin Kidney J; 2023 Nov; 16(11):1925-1935. PubMed ID: 37915916
[TBL] [Abstract][Full Text] [Related]
7. High Prevalence of Cardiovascular Disease in End-Stage Kidney Disease Patients Ongoing Hemodialysis in Peru: Why Should We Care About It?
Bravo-Jaimes K; Whittembury A; Santivañez V
Int J Nephrol; 2015; 2015():568702. PubMed ID: 26294974
[TBL] [Abstract][Full Text] [Related]
8. [Erythropoietin-beta in the treatment of anemia in patients with chronic renal insufficiency].
Dimković N
Med Pregl; 2001; 54(5-6):235-40. PubMed ID: 11759218
[TBL] [Abstract][Full Text] [Related]
9. Epoetin alfa's effect on left ventricular hypertrophy and subsequent mortality.
Jones M; Schenkel B; Just J
Int J Cardiol; 2005 Apr; 100(2):253-65. PubMed ID: 15823633
[TBL] [Abstract][Full Text] [Related]
10. [Diastolic dysfunction in different types of left ventricular hypertrophy in patients with end-stage renal failure: impact of long-term erythropoietin therapy].
Dzgoeva FU; Gatagonova TM; Kadzaeva ZK; Khamitsaeva OV; Kochisova ZKh; Dzueva AT; Bazaeva BG; Bestaeva TL
Ter Arkh; 2013; 85(6):44-50. PubMed ID: 23866598
[TBL] [Abstract][Full Text] [Related]
11. The effects of maintenance recombinant human erythropoietin therapy on ambulatory blood pressure recordings: conventional, Doppler, and tissue Doppler echocardiographic parameters.
Kirkpantur A; Kahraman S; Yilmaz R; Arici M; Altun B; Erdem Y; Yasavul U; Turgan C
Artif Organs; 2005 Dec; 29(12):965-72. PubMed ID: 16305652
[TBL] [Abstract][Full Text] [Related]
12. [Nitric oxide--a potential modulator of left ventricular diastolic function in hemodialysis patients treated with erythropoietin].
Rasić S; Kulenović I; Zulić I; Huskić J; Avdagić N; Babić N; Uncanin S; Haracić A
Med Arh; 2004; 58(2):109-12. PubMed ID: 15202319
[TBL] [Abstract][Full Text] [Related]
13. Effects of levosimendan on left ventricular relaxation and early filling at maintained preload and afterload conditions after aortic valve replacement for aortic stenosis.
Jörgensen K; Bech-Hanssen O; Houltz E; Ricksten SE
Circulation; 2008 Feb; 117(8):1075-81. PubMed ID: 18268152
[TBL] [Abstract][Full Text] [Related]
14. Effect of erythropoietin on cardiovascular prognosis parameters in hemodialysis patients.
Frank H; Heusser K; Höffken B; Huber P; Schmieder RE; Schobel HP
Kidney Int; 2004 Aug; 66(2):832-40. PubMed ID: 15253740
[TBL] [Abstract][Full Text] [Related]
15. Impact of recombinant human erythropoietin treatment on left ventricular hypertrophy and cardiac function in dialysis patients.
Massimetti C; Pontillo D; Feriozzi S; Costantini S; Capezzuto A; Ancarani E
Blood Purif; 1998; 16(6):317-24. PubMed ID: 10343078
[TBL] [Abstract][Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
